Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 501 - 550 of 759 results
- Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
- Effect of hyperforin-enriched extract on pro-ejaculatory effect of 8-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats.
- cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil.
- The effect of vardenafil (a PDE type 5 inhibitor) on renal function in the diabetic rabbit: a pilot study.
- Tolterodine does not affect memory assessed by passive-avoidance response test in mice.
- The discovery of GSK221149A: A potent and selective oxytocin antagonist.
- Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT(2C) receptor agonists.
- Synthesis and evaluation of a gamma-lactam as a highly selective EP(2) and EP(4) receptor agonist.
- Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.
- The age distribution, rates, and types of surgery for stress urinary incontinence in the USA.
- The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers.
- (Phenylpiperazinyl)cyclohexylureas: Discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
- Effects of Continuous versus Cyclic Oral Contraception: A Randomized Controlled Trial.
- Treatment of Hepatitis C in Hemodialysis Patients with Pegylated Interferon alpha-2a as Monotherapy.
- Inhibitory effects of nicorandil, a K(ATP) channel opener and a nitric oxide donor, on overactive bladder in animal models.
- The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
- Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
- Comparative studies of ZD0947, a novel ATP-sensitive K(+) channel opener, on guinea pig detrusor and aortic smooth muscles.
- In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder.
- Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists.
- In vivo study on the effects of alpha(1)-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
- The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study.
- Effect of Saw Palmetto Soft Gel Capsule on Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized Trial in Shanghai, China.
- Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
- Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT(2C) receptor agonists.
- Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.
- Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction.
- Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury.
- The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model.
- Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms in Men (January).
- Lycopene Inhibits Disease Progression in Patients with Benign Prostate Hyperplasia.
- Tadalafil (cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial.
- High-Dose Terazosin Therapy (5mg) in Korean Patients with Lower Urinary Tract Symptoms with or without Concomitant Hypertension: A Prospective, Open-Label Study.
- Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-controlled, double-blind, randomized trial.
- Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors.
- A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis.
- Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study.
- Role of Chloride Channels in the Regulation of Corpus Cavernosum Tone: A Potential Therapeutic Target for Erectile Dysfunction.
- Phosphorylation Increases Affinity of the Phosphodiesterase-5 Catalytic Site for Tadalafil.
- Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
- 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor-1{alpha} and Suppresses Growth of Lesions in a Mouse Model of Endometriosis.
- Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.
- Efficacy of a Novel Device for Assessment of Autonomic Sensory Function in the Rat Bladder.
- Expression of alpha(1)-Adrenoceptor Subtype mRNA as a Predictor of the Efficacy of Subtype Selective alpha(1)-Adrenoceptor Antagonists in the Management of Benign Prostatic Hyperplasia.
- Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study.
- Use of the NuvaRing(R) hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus.
- Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome.
- Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study.
- Gamendazole, an Orally Active Indazole Carboxylic Acid Male Contraceptive Agent, Targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and Stimulates Il1a Transcription in Rat Sertoli Cells.